Neue Studie erschienen: Identification of Borderline Personality Disorder in Adolescents: Psychometric Properties and Diagnostic Efficiency of a Juvenile Version of the Impulsivity and Emotion Dysregulation Scale

Dienstag, 25. März 2025 - 13:46 Uhr

Identification of Borderline Personality Disorder in Adolescents: Psychometric Properties and Diagnostic Efficiency of a Juvenile Version of the Impulsivity and Emotion Dysregulation Scale

Brede, M., Dippold, B., Bender, S., Kröger, C. & Krischer, M. (2025). Identification of Borderline Personality Disorder in Adolescents: Psychometric Properties and Diagnostic Efficiency of a Juvenile Version of the Impulsivity and Emotion Dysregulation Scale (IES‐27‐J). Journal of Clinical Psychology

 

Lesen Sie hier die Ergebnisse.

 

Abstract

Objective

The diagnostic efficiency of screening instruments for adolescents with Borderline Personality Disorder (BPD)—that are applicable to its new classification in DSM-5 and ICD-11—has not yet been sufficiently studied.

Methods

We examined the reliability and diagnostic efficiency of the juvenile version of the Impulsivity and Emotion Dysregulation Scale (IES-27-J) in a German-speaking sample of inpatient 12–19-year-old adolescents (N = 220, including n = 88 with BPD and n = 132 with other mental disorders). Using a receiver operating characteristic (ROC) analysis, optimal cutoff values were determined for this self-report instrument. Analyses were conducted for two different diagnostic thresholds with at least four and five BPD diagnostic criteria, respectively, in accordance with the semi-structured clinical interview International Personality Disorder Examination (IPDE).

Results

Results indicate that the IES-27-J is a reliable and valid instrument with moderate to high discriminative ability (areas under the curve [AUC] = 0.77 and 0.80, respectively). Using the preferred cutoff values, sensitivity (71% and 83%) and specificity (76% and 67%) turned out to be moderate.

Conclusion

The application of the IES-27-J can be considered favorable in a two-stage approach, using a lower cutoff value in a first step to miss fewer patients with BPD, and conducting a clinical interview in a second step to confirm the diagnosis. More studies in different settings, including direct comparisons with other screening instruments, are necessary to further assess the clinical utility of the IES-27-J.